NCT01976364 Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01976169 Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Status COMPLETED Phase PHASE1
NCT01975389 The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects Status TERMINATED Phase PHASE3
NCT01975376 The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects Status TERMINATED Phase PHASE3
NCT01974817 Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease Status COMPLETED Phase PHASE4
NCT01971593 The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease Status TERMINATED Phase PHASE4
NCT01970865 A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations Status COMPLETED Phase PHASE1/PHASE2
NCT01968980 A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT01968967 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events Status COMPLETED Phase PHASE3
NCT01968954 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events Status COMPLETED Phase PHASE3
NCT01965600 A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model Status TERMINATED Phase PHASE1
NCT01964716 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. Status COMPLETED Phase PHASE3
NCT01964079 Comparision of Blood Pressure Variability Between Amlodipine and Losartan Status COMPLETED Phase PHASE4
NCT01962207 The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination Status COMPLETED Phase PHASE3
NCT01959919 Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO Status COMPLETED Phase N/A
NCT01959594 A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT01958671 A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO) Status COMPLETED Phase PHASE3
NCT01953731 A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991) Status COMPLETED Phase PHASE1